Primary aldosteronism associated with subclinical cushing syndrome

Journal of Endocrinological Investigation

Volumn 36, Issue 8, 2013, Pages 564-567

  Fujimoto, K ^a   Honjo, S ^a   Tatsuoka, H ^a   Hamamoto, Y ^a   Kawasaki, Y ^a   Matsuoka, A ^a   Ikeda, H ^a   Wada, Y ^a   Sasano, H ^c   Koshiyama, H ^a,b  

^a Kitano Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal venous sampling; Dexamethasone suppression test; Immunohistochemical analysis; Primary aldosteronism; Subclinical Cushing syndrome

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX ATROPHY; ADRENAL VENOUS SAMPLING; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE RELEASE; HYPERTENSION; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; RETROSPECTIVE STUDY; SUBCLINICAL CUSHING SYNDROME; ZONA FASCICULATA;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; ADULT; CUSHING SYNDROME; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; MALE; MIDDLE AGED;

EID: 84885656182     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8818     Document Type: Article

References (24)

1. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21: 315-8.
2. Komiya I, Yamada T, Takasu N. An abnormal sodium metabolism in Japanese patients with essential hypertension: the renin aldosterone system. J Hypertens 1997, 15: 65-72.
3. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary care population. Lancet 1999, 353: 40.
4. Loh K-C, Koay ES, Khaw M-C, Emmanuel SC, Young WF. Preva - lence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000, 85: 2854-9.
5. Bravo EL. Medical management of primary hyperaldosteronism. Curr Hypertens Res 2001, 3: 406-9.
6. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001, 37: 699-705.
7. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospec - tive study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004, 27: 193-202.
8. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006, 48: 2293-300.
9. Piaditis GP, Kaltsas GA, Androulakis II, et al. High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin Endocrinol (Oxf) 2009, 71: 772-8.
10. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 93: 3266-81.
11. Hiraishi K, Yoshimoto T, Tsuchiya K, et al. Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome. Endocr J 2011, 58: 543-51.
12. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000, 29: 43-56.
13. Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000, 85: 1440-8.
14. Terzolo M, Osella G, Ali A, et al. Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 1998, 48: 89-97.
15. Terzolo M, Bovio S, Pia A, Reimondo G, Angeli A. Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 2009, 23: 233-43.
16. Nishikawa T, Omura M, Satoh F, et al. Guidelines for the diagnosis and treatment of primary aldosteronism - the Japan Endocrine Society 2009. Endocr J 2011, 58: 711-21.
17. Nawata H, Demura T, Suda T, Takayanagi R. Adrenal preclinical Cushing's syndrome, in Annual Report of the Ministry of Health and Welfare "Disorders of Adrenal Hormones" Research Committee. Japan 1996, 223-6 (In Japanese).
18. Sasano H, Miyazaki S, Sawai T, et al. Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Mod Pathol 1992, 5: 23-9.
19. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin ndocrinol Metab 2008, 93: 1526-40.
20. NIH State-of-the-Science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens State Sci Statements 2002, 19: 1-25.
21. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentalomas"). Ann Intern Med 2003, 138: 424-9.
22. Nakajima Y, Yamada M, Taguchi R, et al. Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab 2011, 96: 2512-8.
23. Matsuda A, Beniko M, Ikota A, et al. Primary aldosteronism with bilateral multiple aldosterone-producing adrenal adenomas. Intern Med 1996, 35: 970-5.
24. Watanabe N, Tsunoda K, Sasano H, et al. Bilateral aldosteroneproducing adenomas in two patients diagnosed by immunohistochemical analysis of steroidogenic enzymes. Tohoku J Exp Med 1996, 179: 123-9.